Delivery Order SPE2DR25D1017-SPE2DR26F8YEC
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 19, 2025, by the Defense Logistics Agency (DLA) to supply ORGOVYX 120 MG tablets in quantities of 30 units. The contract is valued at $1,385.52 with a firm fixed price structure and does not utilize a set-aside designation. Performance is scheduled for completion by September 10, 2025, and will be fulfilled at the awardee's Conshohocken, Pennsylvania...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 11, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a contract ceiling value of $2,771.04. The award represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025. This contract was competitively awarded without set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain, a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 25, 2025, for the supply of ORGOVYX 120 MG tablets in quantities of 30 units, with a ceiling value of $2,771.04 and a firm fixed price contract type. This delivery order represents a non-set-aside award and is expected to be completed by October 17, 2025. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-focused procurement entity...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $8,313.12 for ORGOVYX 120 mg tablets (30-count unit dose). The contract, awarded on September 19, 2025, with an ultimate completion date of October 10, 2025, carries firm fixed pricing and no set-aside designation. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,385.52 for ORGOVYX 120 mg tablets (30-unit package) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,313.12 on July 29, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) on September 23, 2025, with an ultimate completion date of October 15, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a ceiling value of $1,460.13 and a firm fixed-price structure. The contract is non-set-aside and competitively awarded, with an ultimate completion date of November 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) with a firm fixed price arrangement. The contract, awarded on August 27, 2025, is classified as a non-set-aside competitive award with an ultimate completion date of September 18, 2025. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $8,313.12 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of ORGOVYX 120 mg tablets (30-count unit of use packaging). This firm fixed-price contract, with a completion date of September 25, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was made through open competition...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F8YECDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on October 20, 2025, for ORGOVYX 120 mg tablets in quantities of 30 units. The contract is valued at $1,460.13 with a firm fixed price structure and an ultimate completion date of November 10, 2025. This delivery order was issued under no set-aside provision, demonstrating the contractor's ability to compete in open federal procurement. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical support mechanism for military healthcare programs globally. AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting Defense Health Agency and military healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering a broad spectrum of pharmaceutical products, including specialty medications, generic drugs, and medical supplies across multiple therapeutic domains. As a major healthcare solutions provider registered in the System for Award Management (SAM.gov), the contractor consistently fulfills federal medical supply requirements through delivery orders ranging from small transactions to substantial orders, reflecting its versatility and capability to support ongoing defense medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/20/25 |